|
|
|
Impact factor: 3.241
|
|
|
|
|
|
ISSN: 1040-8401 Print
|
|
|
|
| |
You can order a single issue or an individual article, as well as view the table of contents or article abstract by clicking on the volume number, then the issue number in the right sidebar.
|
|
|
|
|
|
Institutional price: $942.00
|
|
Online subscription
|
|
DOI: 10.1615/CritRevImmunol.v25.i2
Pages: 90
|
DOI: 10.1615/CritRevImmunol.v25.i2.10
|
Article price - $40.00 |
 |
Th1 and Th2 Lymphocytes in Autoimmune Disease
Isabel J. Crane
Department of Ophthalmology, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK
John V. Forrester
Department of Ophthalmology, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK
ABSTRACT
This review reconsiders how the Th1/Th2 paradigm can be applied to Th1-mediated autoimmune disease. Although there is evidence that autoimmune diseases such as multiple sclerosis, type 1 insulin-dependent diabetes mellitus, and posterior uveitis are Th1 mediated and that in some cases reduction of the Th1 response or a Th2 type shift may alleviate disease, many apparent exceptions are now well documented. These exceptions center around the contradictory actions of the Th1 cytokine IFN-γ and the evidence that Th2 lymphocytes can also cause disease. Recent information on the regulation of Th1 and Th2 lymphocytes in terms of the innate immune response and by other T cells helps to clarify the reasons for some of these discrepancies and enables the Th1/Th2 concept to be accepted as an integral part of the complex interactions occurring as autoimmune disease develops.
pages 75-102
|
|
Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999
|
|
|
|
|
|
